FDA clearance

Colin Kerr

Posted: Thursday, February 1, 2018

Topcon Medical Systems has announced that its PASCAL Laser has received FDA clearance (K171488) to offer Pattern Scanning Laser Trabeculoplasty (PSLT) for the reduction of intraocular pressure (IOP) associated with glaucoma.

PSLT is an advanced tissue-sparing laser treatment for reducing intraocular pressure in open-angle glaucoma.

“The availability of PSLT, offers now a clinically-proven glaucoma treatment technology to ophthalmologists in the US,” said Robert Gibson, Vice President, Eye Care Global Marketing, Topcon Corporation.

“Globally, we’ve seen success with the Streamline PSLT application and believe glaucoma specialists and comprehensive ophthalmologists in the United States will find this technology a useful addition to their treatment armamentarium.”